Advertisement

Archives of Dermatological Research

, Volume 307, Issue 3, pp 199–209 | Cite as

Current knowledge in Polypodium leucotomos effect on skin protection

Review

Abstract

This article provides an overview of pharmacology, toxicity, pharmacokinetics and clinical data of Polypodium leucotomos L. (PL). PL aerial part has proven to exert antioxidant, photoprotective and immunomodulatory activities; its mechanism of action is complex and includes several activities: (1) PL diminishes the production of reactive oxygen and nitrogen species (ROS, RNS); (2) PL inhibits the photoisomerization of trans-urocanic acid (t-UCA); (3) PL inhibits apoptosis induced by ultraviolet radiation; (4) PL prevents damage to genetic material and (5) PL enhances DNA repair. PL is not mutagenic and does not induce acute or chronic toxicity. Its biological effects have been proved in cell cultures, animal models, murine models and in human beings. Photoprotective activity has been assessed in healthy volunteers as well as in patients suffering from several cutaneous diseases such as vitiligo, psoriasis, idiopathic photodermatosis or melasma. PL results to be an efficient treatment especially for sensitive cutaneous phototypes and adds extra protection when ultraviolet radiation (UVR) exposure cannot be avoided, such as wide or narrow band UVB phototherapy or treatment with psoralens plus UVA exposure radiation.

Keywords

Polypodium leucotomos Photoprotection UV radiation Pharmacodynamics Clinical studies 

Notes

Acknowledgments

The author thanks Dr. Eduardo Reyes for his assistance in the clinical data analysis.

References

  1. 1.
    Aguilera P, Carrera C, Puig-Butille JA, Badenas C, Lecha M, Gonzalez S, Malvehy J, Puig S (2013) Benefits of oral Polypodium leucotomos extract in MM high-risk patients. J Eur Acad Dermatol Venereol 27(9):1095–1100CrossRefPubMedGoogle Scholar
  2. 2.
    Alonso-Lebrero JL, Domínguez-Jiménez C, Tejedor R, Brieva A, Pivel JP (2003) Photoprotective properties of a hydrophilic extract of the fern Polypodium leucotomos on human skin cells. J Photochem Photobiol B 70:31–37CrossRefPubMedGoogle Scholar
  3. 3.
    Azuma K, Ippoushi K, Nakayama M, Ito H, Higashio H, Terao J (2000) Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J Agric Food Chem 48:5496–5500CrossRefPubMedGoogle Scholar
  4. 4.
    Breithaupt AD, Jacob SE (2012) Subacute Cutaneous Lupus Erythematosus: a case report of Polypodium leucotomos as an adjuvant therapy. Cutis 89:183–184PubMedGoogle Scholar
  5. 5.
    Caccialanza M, Percivalle S, Piccinno R, Brambilla R (2007) Photoprotective activity of oral Polypodium leucotomos extract in 25 patients with idiopathic photodermatoses. Photodermatol Photoimmunol Photomed 23(1):46–47CrossRefPubMedGoogle Scholar
  6. 6.
    Caccialanza M, Recalti S, Piccinno R (2011) Oral Polypodium leucotomos extract photoprotective activity in 57 patients with idiopathic photodermatoses. G Ital Dermatol Venereol 146:85–87PubMedGoogle Scholar
  7. 7.
    Capote R, Alonso-Lebrero J, García F, Brieva A, Pivel JP, Gonzalez S (2006) Polypodium leuctomos extract inhibits trans-urocanic acid photoisomerization and photodecomposition. J Phytochem Photobiol 82:173–179CrossRefGoogle Scholar
  8. 8.
    De las Heras ME, Ledo E, Gonzalez S, Rocamora A, Ledo A (1997) An extract of Polypodium leucotomos (Difur) as an adyuvant to PUVA therapy. Med Cutan Iber 25:103–107Google Scholar
  9. 9.
    Dummer R, Maier T (2002) UV protection and skin cancer. Recent Results Canc Res 160:7–12CrossRefGoogle Scholar
  10. 10.
    Enta T, Kwan TY (1998) Melanocytic nevi in sun-protected Canadian Hutterite children. Arch Dermatol 134:379–381CrossRefPubMedGoogle Scholar
  11. 11.
    Garcia F, Pivel JP, Guerrero A et al (2006) Phenolic components and antioxidant activity of Fernblock, an aqueous extract of the aerial parts of the fern Polypodium leucotomos. Methods Find Exp Clin Pharmacol 28:157–160CrossRefPubMedGoogle Scholar
  12. 12.
    Gombau L, García F, Lahoz A, Fabre M, Roda-Navarro P, Majano P, Alonso-Lebrero JL, Pivel JP, Castell JV, Gómez-Lechon MJ, Gonzalez S (2006) Polypodium leucotomos extract: antioxidant activity and disposition. Toxicol In Vitro 20:464–471CrossRefPubMedGoogle Scholar
  13. 13.
    Gomes AJ, Lunardi CN, Gonzalez S, Tudesco AC (2001) The antioxidant action of Polypodium leucotomos extract and kojic acid: reactions with reactive oxygen species. Braz J Med Biol Res 34:1487–1494PubMedGoogle Scholar
  14. 14.
    Gonzalez S, Alcaraz MV, Cuevas J, Pérez M, Jaén P, Alvarez-Mon M, Villarrubia VG (2000) An extract of the fern Polypodium leucotomos (Difur®) modulates Th1/Th2 cytokines balance in vitro and appears to exhibit anti-angiogenic activities in vivo: pathogenic relationships and therapeutic indications. Anticancer Res 20:1567–1576PubMedGoogle Scholar
  15. 15.
    Gonzalez S, Alonso-Lebrero JL, Del Río R, Jaén P (2007) Polypodium leucotomos extract: a nutraceutical with photoprotective properties. Drugs Today 43(7):475–485CrossRefPubMedGoogle Scholar
  16. 16.
    Gonzalez S, Fernández-Lorente M, Gilaberte-Calzada Y (2008) The latest on skin photoprotection. Clin Dermatol 26(6):614–626CrossRefPubMedGoogle Scholar
  17. 17.
    Gonzalez S, Gilaberte Y, Philips N, Juarranz A (2011) Current Trends in Photoprotection – A new generation of oral photoprotectors. Open Dermatol J 5:1–9CrossRefGoogle Scholar
  18. 18.
    Gonzalez S, Joshi PC, Pathak MA (1994) Polypodium leucotomos extract as an antioxidant agent in the therapy of skin disorders. J Invest Dermatol 102(4):651–659Google Scholar
  19. 19.
    Gonzalez S, Pathak MA, Cuevas J, Villarubia VG, Fitzpatrick TB (1997) Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psolaren-induced phototoxic reactions as well as depletion of Langerhans cells in human skin. Photodermatol Photoimmunol Photomed 13:50–60CrossRefPubMedGoogle Scholar
  20. 20.
    Gonzalez S, Pathak MA (1996) Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by Polypodium leucotomos. Photodermatol Photoimmunol Photomed 12:45–56CrossRefPubMedGoogle Scholar
  21. 21.
    Hart PH, Grimbaldeston MA, Swift GJ et al (1999) A critical role for dermal mast cells in cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses in mice. Photochem Photobiol 70:807–812CrossRefPubMedGoogle Scholar
  22. 22.
    Hassler M, Swale B. (2001). Checklist of ferns and fern allies. Available at http://homepages.caverock.net.nz/~bj/fern/phlebodium.htm. Accessed 14 Jan 2014
  23. 23.
    Horvath A, Alvarado F, Szocs J, de Alvardo ZA, Padilla G (1967) Metabolic effects of calagualine, an antitumoral saponin of Polypodium leucotomos. Nature 214:1256–1258CrossRefPubMedGoogle Scholar
  24. 24.
    Janczyk A, García-López MA, Fernández-Peñas P, Alonso-Lebrero JL, Benedicto I, López-Cabrera M, Gonzalez S (2007) A Polypodium leucotomos extract inhibits solar-simulated radiation-induced TF-α and iNOS expression, transcriptional activation and apoptosis. Experimental Dermatol 16:823–829CrossRefGoogle Scholar
  25. 25.
    Jiménez D, Naranjo R, Doblare E, Munoz C, Vargas JF (1987) Anapsos, an antipsoriatic drug in atopic dermatitis. Allergol Immunopathol (Madr) 15:185–189Google Scholar
  26. 26.
    Konda S, Geria AN, Halder RM (2012) New horizons in treating disorders of hyperpigmentation in skin of color. Semin Cutan Med Surg 31:133–139CrossRefPubMedGoogle Scholar
  27. 27.
    Kripke ML, Cox PA, Alas LG, Yarosh DB (1992) Pyrimidine dimers in DNA initiate systemic immunosupression in UV-irradiated mice. Proc Natl Acad Sci USA 89:7516–7520CrossRefPubMedCentralPubMedGoogle Scholar
  28. 28.
    Kurimoto I, Streilein JW (1992) Deleterious effects of cis-urocanic acid and UVB radiation on Langerhans cells and on induction of contact hypersensitivity are mediated by tumor necrosis factor-alpha. J Invest Dermatol 99:69S–70SCrossRefPubMedGoogle Scholar
  29. 29.
    Leffell DJ (2000) The scientific basis of skin cancer. J Am Acad Dermatol 42(1 Pt 2):18–22CrossRefPubMedGoogle Scholar
  30. 30.
    Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL (1977) Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol 68:328–335CrossRefPubMedGoogle Scholar
  31. 31.
    Mercadal Peyri O, Maesci Cappitanio F (1981) Preliminary communication on the treatment of psoriasis with anapsos. Actas Dermosifiliogr 72:65–68PubMedGoogle Scholar
  32. 32.
    Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W (2007) Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. J Eur Acad Dermatol Venereol 21:942–950CrossRefPubMedGoogle Scholar
  33. 33.
    Middelkamp-Hup MA, Pathak MA, Parrado C, Garcia-Caballero T, Rius-Diaz F, Fitzpatrick TB, Gonzalez S (2004) Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin. J Am Acad Dermatol 50:41–49CrossRefPubMedGoogle Scholar
  34. 34.
    Middelkamp-Hup MA, Pathak MA, Parrado C, Goukassian D, Rius-Diaz F, Mihm MC, Fitzpatrick TB, Gonzalez S (2004) Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. J Am Acad Dermatol 51(6):910–918CrossRefPubMedGoogle Scholar
  35. 35.
    Mohammad A (1989) Vitiligo repigmentation with Anapsos (Polypodium leucotomos). Int J Dermatol 28(7):479PubMedGoogle Scholar
  36. 36.
    Mulero M, Rodríguez-Yanes E, Nogués MR, Giralt M, Romeu M, Gonzalez S, Mallo J (2008) Polypodium leucotomos extract inhibits glutathione oxidation and prevents Langerhans cell depletion induced by UVB/UVA radiation in a hairless rat model. Exp Dermatol 17:653–658CrossRefPubMedGoogle Scholar
  37. 37.
    Philips N, Smith J, Séller T, Gonzalez S (2003) Predominant effect of Polypodium leucotomos on membrane integrity, lipid peroxidation expression of elastin and matrixmetalloproteinase-1 in ultraviolet radiation exposed fibroblasts, and keratinocytes. J Dermatol Sci 32:1–9CrossRefPubMedGoogle Scholar
  38. 38.
    Ramírez-Bosca A, Zapater P, Betlloch I, Albero F, Martinez A, Díaz-Alperi J, Horga JF (2012) Extracto de Polypodium leucotomos en dermatitis atópica: ensayo multicéntrico, aleatorizado, doble ciego y controlado con placebo. Actas Dermosifilogr 103:599–607CrossRefGoogle Scholar
  39. 39.
    Rattis FM, Concha M, Dalbiez-Gauthier C, Courtellmont P, Scmitt D, Peguet-Navarrol J (1998) Effects of UVB radiation on human Langerhans cells: functional alteration of CD86 upregulation and induction of apoptotic cell death. J Invest Dermatol 111:373–379CrossRefPubMedGoogle Scholar
  40. 40.
    Reyes E, Vitale MA. (2013) Advances in photoprotection. Molecular mechanisms. Piel 28(4): 235–247. Available at http://dx.doi.org/10.1016/j.piel.2012.04.011
  41. 41.
    Richters CD, Reits EA, Van Pelt AM, Hoekstra MJ, Van Baare J, Du Pont JS, Kamperdijk MJ (1996) Effect of low dose UVB radiation on the migratory properties and functional capacities of human skin dendritic cells. Clin Exp Immunol 1004:191–197CrossRefGoogle Scholar
  42. 42.
    Rodríguez-Yanes E, Juarranz A, Cuevas J, Gonzalez S, Mallo J (2012) Polypodium leucotomos decreases UV-induced epidermal cell proliferation and enhances p53 expression and plasma antioxidant capacity in hairless mice. Exp Dermatol 21:630–642CrossRefGoogle Scholar
  43. 43.
    Romeu M, Mulero M, Giralt M, Folch J, Nogués MR, Torres A, Sureda FX, Cabré M, Paternáin JL, Mallo J (2002) Parameters related to oxygen free radicals in erythrocytes, plasma and epidermis of the hairless rat. Life Sci 71:1739–1749CrossRefPubMedGoogle Scholar
  44. 44.
    Saija A, Tomaino A, Lo Cascio R et al (1999) Ferulic and caffeic acids as potencial protective agents against photooxidative skin damage. J Sci Food Agric 79:476–480CrossRefGoogle Scholar
  45. 45.
    Saija A, Tomaino A, Trombetta D et al (2000) In vitro e in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents. Int J Pharm 199:39–47CrossRefPubMedGoogle Scholar
  46. 46.
    Scharffetter-Kochanek K, Wlaschek M, Brenneisen P, Schauen M, Blaudschun R, Wenk J (1997) UV-induced reactive oxygen species in photocarcinogenesis and photoaging. Biol Chem 378(11):1247–1257PubMedGoogle Scholar
  47. 47.
    Simon JC, Tigelaar RE, Bergstresser PR et al (1991) Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. induction of specific clonal anergy in CD4 + T helper 1 cells. J Immunol. 146:485–491PubMedGoogle Scholar
  48. 48.
    Sinclair C (2006) Risks and benefits of sun exposure: implications for public health practice based on the Australian experience. Prog Biophys Mol Biol 92:173–178CrossRefPubMedGoogle Scholar
  49. 49.
    Siscovick JR, Zapolanski T, Magro C, Carrington K, Prograis S, Nussbaum M, Gonzalez S, Ding W, Granstein R (2008) Polypodium leucotomos inhibits ultraviolet B radiation-induced immunosupression. Photodermatol Photoimmunol Photomed 24:134–141CrossRefPubMedGoogle Scholar
  50. 50.
    Tanaka T, Kojima T, Kawamori T et al (1993) Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 14:1231–1325CrossRefGoogle Scholar
  51. 51.
    Tanaka T, Kojima T, Kawamori T, Yoshimi N, Mori H (1993) Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Res 53:2775–2779PubMedGoogle Scholar
  52. 52.
    Tanew A, Radakovic S, Gonzalez S, Venturini M, Calzavara-Pinton P (2012) Oral administration of a hydrophilic extract of Polypodium leucotomos for the prevention of polymorphic light eruption. J Am Acad Dermatol 66:58–62CrossRefPubMedGoogle Scholar
  53. 53.
    Williamson G, Day AJ, Pluma GW, Couteau D (2000) Human metabolic pathways of dietary flavonoids and cinnamates. Biochem Soc Trans 28:16–22PubMedGoogle Scholar

Related articles recently published in Archives of Dermatological Research (selected by the journal’s editorial staff)

  1. 54.
    Ishii Y, Sugimoto S, Izawa N, Sone T, Chiba K, Miyazaki K (2014) Oral administration of Bifidobacterium breve attenuates UV-induced barrier perturbation and oxidative stress in hairless mice skin. Arch Dermatol Res 306:467–473CrossRefPubMedGoogle Scholar
  2. 55.
    Muthusamy V, Piva TJ (2013) A comparative study of UV-induced cell signalling pathways in human keratinocyte-derived cell lines. Arch Dermatol Res 305:817–833CrossRefPubMedGoogle Scholar
  3. 56.
    Narbutt J, Olejniczak I, Sobolewska-Sztychny D, Sysa-Jedrzejowska A, Slowik-Kwiatkowska I, Hawro T, Lesiak A (2013) Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients. Arch Dermatol Res 305:191–195CrossRefPubMedCentralPubMedGoogle Scholar
  4. 57.
    Xu D, Yuan R, Gu H, Liu T, Tu Y, Yang Z, He L (2013) The effect of ultraviolet radiation on the transforming growth factor beta 1/Smads pathway and p53 in actinic keratosis and normal skin. Arch Dermatol Res 305:777–786CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Pharmacology, Faculty of PharmacyUniversidad Complutense de MadridMadridSpain

Personalised recommendations